3D-QSAR Studies of Novel Cytotoxic Bufadienolides via CoMFA and CoMSIA Approaches

被引：2

作者：

Lin, Hui ^{[1
]}

Li, Shengrong ^{[1
]}

Li, Shiyao ^{[1
]}

Liu, Kangjia ^{[1
]}

Han, Yushui ^{[1
]}

Guo, Jialiang ^{[1
]}

Lin, Longxin ^{[2
]}

Chang, Yiqun ^{[1
]}

Xiao, Gaokeng ^{[1
]}

Chen, Weimin ^{[1
]}

Sun, Pinghua ^{[1
]}

机构：

[1] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituent, Guangzhou 510632, Guangdong, Peoples R China

[2] Jinan Univ, Coll Informat Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China

来源：

LETTERS IN DRUG DESIGN & DISCOVERY | 2017年 / 14卷 / 03期

关键词：

CoMFA; CoMSIA; QSAR; bufadienolides; cytotoxic activities; TOAD POISON BUFADIENOLIDES; BUFO-BUFO-GARGARIZANS; CHAN-SU; QSAR MODELS; INHIBITORS; DOCKING; DERIVATIVES; BIOTRANSFORMATION; IDENTIFICATION; VALIDATION;

D O I：

10.2174/1570180813666160906150621

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Background: Biotransformed bufadienolides are new kind of cytotoxic products with novel structures. Method: Herein, 3D-QSAR analyses were performed on bufadienolides using CoMFA and CoMSIA to learn the structure-activity relationship and the mechanism of action of these compounds. The cross-validated q(2)value of CoMFA is 0.648 and q(2) value of CoMSIA is 0.635. The non-crossvalidated r(2) value of CoMFA is 0.963 and r(2) values of CoMSIA is 0.961. The 3D-QSAR models we obtained were illustrated through CoMFA and CoMSIA contour plots. Results: That will be valuable in predicting cytotoxic activities against cancer cells, and could be used to design potent anticancer drugs.

引用

页码：306 / 313

页数：8

共 50 条

[21] 3D-QSAR CoMFA and CoMSIA studies on a set of diverse α1a-adrenergic receptor antagonists
Amit K. Gupta
Anil K. Saxena
Medicinal Chemistry Research, 2011, 20 : 1455 - 1464
[22] 3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5α-reductase inhibitors
Rajnish Kumar
Manoj Kumar
Medicinal Chemistry Research, 2013, 22 : 105 - 114
[23] 3D-QSAR CoMFA and CoMSIA studies on a set of diverse α1a-adrenergic receptor antagonists
Gupta, Amit K.
Saxena, Anil K.
MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (09) : 1455 - 1464
[24] CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase
Santos-Filho, Osvaldo A.
Forge, Delphine
Hoelz, Lucas V. B.
de Freitas, Guilherme B. L.
Marinho, Thiago O.
Araujo, Jocley Q.
Albuquerque, Magaly G.
de Alencastro, Ricardo B.
Boechat, Nubia
JOURNAL OF MOLECULAR MODELING, 2012, 18 (09) : 4061 - 4072
[25] 3D-QSAR CoMFA/CoMSIA studies on urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents
Bhongade, BA
Gadad, AK
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (10) : 2797 - 2805
[26] CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase
Osvaldo A. Santos-Filho
Delphine Forge
Lucas V. B. Hoelz
Guilherme B. L. de Freitas
Thiago O. Marinho
Jocley Q. Araújo
Magaly G. Albuquerque
Ricardo B. de Alencastro
Nubia Boechat
Journal of Molecular Modeling, 2012, 18 : 4061 - 4072
[27] 3D-QSAR Analysis on ATR Protein Kinase Inhibitors Using CoMFA and CoMSIA
Li, Xiurong
Shu, Mao
Wang, Yuanqiang
Yu, Rui
Yao, Shuang
Lin, Zhihua
CURRENT COMPUTER-AIDED DRUG DESIGN, 2014, 10 (04) : 327 - 334
[28] CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors
Ul-Haq, Zaheer
Wadood, Abdul
Uddin, Reaz
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (01) : 272 - 278
[29] 3D-QSAR analysis on ATR protein kinase inhibitors using CoMFA and CoMSIA
Li, Xiurong
Shu, Mao
Wang, Yuanqiang
Yu, Rui
Yao, Shuang
Lin, Zhihua
Current Computer-Aided Drug Design, 2015, 10 (04) : 327 - 334
[30] Exploring 3D-QSAR for Ketolide Derivatives as Antibacterial Agents Using CoMFA and CoMSIA
Song, Qiu-Ling
Sun, Ping-Hua
Chen, Wei-Min
LETTERS IN DRUG DESIGN & DISCOVERY, 2010, 7 (03) : 149 - 159

← 1 2 3 4 5 →